BIOMAKERS is a Precision Medicine & Genetic Innovation Company that focuses on Oncology and Rare Diseases.
BMK have performed over 150,000 genomic tests on advanced cancer patients from Latin America, building the largest late-stage tumor biobank in LATAM.
With local operations in Brazil, Mexico, and Argentina, thousands of patients from over 10 Latin American countries are actively tested on a daily basis.
BIOMAKERS' global client portfolio includes 15 major pharmaceutical companies, and we are developing platforms with AI to determine the best treatment pathway for each advanced cancer patient.